In the past quarter, the profit growth rate of the dental equipment manufacturing industry has shown a notable decline, with internal divergence becoming increasingly prominent. Companies such as Dencare and HILE have achieved double-digit or even triple-digit revenue growth, while Zhenghai Biology is facing pressure from revenue decline.
Meanwhile, a series of standardization documents intensively released in October, ranging from toothpaste classification to custom Dental Prosthesis inspection and AI technical requirements, are gradually filling the gaps in the regulatory framework. Rising compliance costs are reshaping the competitive landscape for enterprises and significantly enhancing industry transparency.
Against the backdrop of regulatory calibration, domestic enterprises need to find a balance between compliance and innovation, while companies expanding overseas must confront the severe test of patent red lines. Which factors will determine the direction of the next round of growth? Let us wait and see...
This content is available to DentalGoodNews Pro members. Subscribe to read full article